Healthcare

PRODUCTS

  • The leader in digitizing validation

    Setting the digital validation standard for 20 years, ValGenesis VLMS is used by 30 of the top 50 global life sciences companies.

    The gold standard of standardization

    Strengthen your compliance stance and lower the cost of quality with enforced standardization and absolute data integrity.

    Knowledge integrity to data integrity

    Gain total peace of mind with a single source of validation truth with documentation aligned to ALCOA+ standards.

    One platform, boundless scale

    Start small or start global. VLMS scales effortlessly to support new systems, new sites, new products, new languages, and new validation processes.

  • By removing barriers, and bringing trials to patients where they live, we can expand the geographical reach of clinical research across the globe allowing more patients to participate. Our patient-centric delivery means we can create convenience and comfort working the schedule of the trial around the schedule of the patient and their family, not the other way around. This approach provides important access to medical care, enhances the inclusivity of clinical trials and advances drug development for all.

  • “Going the extra mile is a big part of our DNA. Personal attention can go a long way in ensuring the success of your next research study.”

    Raffaella Hart, MS, CIP
    Sr. Vice President, IRB and IBC Services

    Fast, reliable IRB review for multisite studies backed by expert oversight and responsive support. With streamlined submissions, frequent meetings, and dedicated client managers, BRANY IRB helps you save time and money while maintaining full regulatory compliance.

  • Drive your program forward with an experienced partner ready to execute early-phase clinical research with exceptional speed and scientific rigor.

  • Fetal Bovine Serum (FBS) is a time tested, universal supplement used in cell culture. It provides many compounds that have been shown to satisfy specific metabolic requirements for the culture of cells, including hormones, growth factors, cell attachment factors, pH buffer, protease inhibitors, vitamins, minerals, lipids, and a variety of undefined components.

WHITE PAPERS AND CASE STUDIES

NEWS

  • Study Finds Coastal Flooding More Frequent Than Previously Thought
    6/4/2025

    Flooding in coastal communities is happening far more often than previously thought, according to a new study from North Carolina State University and the University of North Carolina at Chapel Hill. The study also found major flaws with the widely used approach of using marine water level data to capture instances of flooding.

  • St. Jude Algorithm Puts Water To Work In Drug Discovery
    6/27/2025

    Every protein in the body is encased in a water shell that directs protein structure, provides vital stability and steers function. Because of this, water molecules represent a powerful but largely underappreciated foothold in drug binding studies.

  • GE HealthCare Collaborates With Two Major Medical Systems To Advance AI Technology Designed To Transform Hospital Operations And Improve Patient Care
    10/20/2025

    GE HealthCare today announced collaborations with two leading U.S. health systems—The Queen’s Health Systems in Honolulu, HI and Duke Health in Durham, NC—to help advance the development of GE HealthCare’s new AI-driven hospital operations software.

  • ActiGraph Accelerates Clinical Trial Modernization With Transformational Acquisition Of Biofourmis Life Science Business
    1/22/2025

    ActiGraph, the global leader in wearable digital health technology for clinical research and development, has announced the acquisition of Biofourmis Connect, a division of Biofourmis that delivers an AI-driven, digital trial platform tailored for the life science industry.  The combined solution will create a market-leading, unified software and data ecosystem for the modernization of clinical research throughout the drug-product lifecycle and across therapeutic areas.

  • AmpliTech Group Announces Innovative True 5G Technology Development
    2/20/2025

    AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today announced, it is setting the record straight on what constitutes True 5G and how its revolutionary technology is paving the way for the future of wireless connectivity.